Citigroup’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $285M | Buy |
1,310,600
+111,700
| +9% | +$24.8M | 0.12% | 161 |
|
|
2025
Q4 | $274M | Buy |
1,198,900
+94,300
| +9% | +$21.5M | 0.12% | 144 |
|
|
2025
Q3 | $256M | Buy |
1,104,600
+81,400
| +8% | +$16.6M | 0.11% | 167 |
|
|
2025
Q2 | $190M | Buy |
1,023,200
+53,600
| +6% | +$9.96M | 0.09% | 209 |
|
|
2025
Q1 | $203M | Sell |
969,600
-627,400
| -39% | -$122M | 0.1% | 175 |
|
|
2024
Q4 | $284M | Buy |
1,597,000
+660,100
| +70% | +$121M | 0.17% | 109 |
|
|
2024
Q3 | $185M | Buy |
936,900
+118,600
| +14% | +$22.1M | 0.11% | 167 |
|
|
2024
Q2 | $140M | Buy |
818,300
+43,900
| +6% | +$7.27M | 0.09% | 194 |
|
|
2024
Q1 | $141M | Buy |
774,400
+31,700
| +4% | +$5.46M | 0.09% | 206 |
|
|
2023
Q4 | $115M | Buy |
742,700
+37,000
| +5% | +$5.39M | 0.08% | 223 |
|
|
2023
Q3 | $105M | Sell |
705,700
-55,800
| -7% | -$8.19M | 0.08% | 220 |
|
|
2023
Q2 | $103M | Buy |
761,500
+420,300
| +123% | +$61.6M | 0.07% | 228 |
|
|
2023
Q1 | $54.4M | Sell |
341,200
-128,200
| -27% | -$19.6M | 0.04% | 376 |
|
|
2022
Q4 | $75.9M | Buy |
469,400
+72,300
| +18% | +$11.1M | 0.06% | 288 |
|
|
2022
Q3 | $53.3M | Sell |
397,100
-77,500
| -16% | -$11.1M | 0.04% | 355 |
|
|
2022
Q2 | $72.7M | Sell |
474,600
-441,800
| -48% | -$67.5M | 0.05% | 281 |
|
|
2022
Q1 | $149M | Sell |
916,400
-660,300
| -42% | -$95.9M | 0.09% | 192 |
|
|
2021
Q4 | $213M | Buy |
1,576,700
+583,600
| +59% | +$68.9M | 0.11% | 158 |
|
|
2021
Q3 | $107M | Sell |
993,100
-119,100
| -11% | -$13.6M | 0.06% | 267 |
|
|
2021
Q2 | $125M | Buy |
1,112,200
+254,100
| +30% | +$28.6M | 0.08% | 239 |
|
|
2021
Q1 | $92.9M | Buy |
858,100
+97,548
| +13% | +$10.4M | 0.06% | 294 |
|
|
2020
Q4 | $81.5M | Buy |
760,552
+132,826
| +21% | +$12.8M | 0.05% | 339 |
|
|
2020
Q3 | $55M | Buy |
627,726
+99,556
| +19% | +$9.37M | 0.04% | 412 |
|
|
2020
Q2 | $51.9M | Sell |
528,170
-476,130
| -47% | -$41.9M | 0.04% | 383 |
|
|
2020
Q1 | $76.5M | Sell |
1,004,300
-319,000
| -24% | -$27.2M | 0.07% | 236 |
|
|
2019
Q4 | $117M | Buy |
1,323,300
+11,000
| +0.8% | +$913K | 0.08% | 205 |
|
|
2019
Q3 | $99.4M | Sell |
1,312,300
-153,800
| -10% | -$10.5M | 0.08% | 232 |
|
|
2019
Q2 | $107M | Buy |
1,466,100
+261,600
| +22% | +$20.6M | 0.09% | 213 |
|
|
2019
Q1 | $97.1M | Buy |
1,204,500
+617,400
| +105% | +$50.5M | 0.09% | 194 |
|
|
2018
Q4 | $54.1M | Buy |
587,100
+110,700
| +23% | +$9.73M | 0.05% | 380 |
|
|
2018
Q3 | $45.1M | Buy |
476,400
+222,100
| +87% | +$21.1M | 0.04% | 434 |
|
|
2018
Q2 | $23.6M | Sell |
254,300
-208,600
| -45% | -$20.4M | 0.02% | 712 |
|
|
2018
Q1 | $43.8M | Sell |
462,900
-154,700
| -25% | -$17M | 0.04% | 437 |
|
|
2017
Q4 | $59.7M | Sell |
617,600
-23,400
| -4% | -$2.21M | 0.05% | 374 |
|
|
2017
Q3 | $57M | Buy |
641,000
+86,200
| +16% | +$6.56M | 0.05% | 350 |
|
|
2017
Q2 | $40.2M | Sell |
554,800
-214,700
| -28% | -$14.4M | 0.04% | 434 |
|
|
2017
Q1 | $50.1M | Sell |
769,500
-492,830
| -39% | -$31M | 0.04% | 360 |
|
|
2016
Q4 | $79M | Buy |
1,262,330
+306,634
| +32% | +$18.7M | 0.07% | 264 |
|
|
2016
Q3 | $60.3M | Buy |
955,696
+42,700
| +5% | +$2.76M | 0.06% | 293 |
|
|
2016
Q2 | $56.5M | Buy |
912,996
+565,000
| +162% | +$34.4M | 0.06% | 300 |
|
|
2016
Q1 | $19.9M | Sell |
347,996
-954,776
| -73% | -$53.2M | 0.02% | 603 |
|
|
2015
Q4 | $77.2M | Sell |
1,302,772
-19,304
| -1% | -$1.11M | 0.08% | 236 |
|
|
2015
Q3 | $71.9M | Sell |
1,322,076
-38,454
| -3% | -$2.5M | 0.07% | 248 |
|
|
2015
Q2 | $91.4M | Buy |
1,360,530
+319,930
| +31% | +$20.9M | 0.08% | 223 |
|
|
2015
Q1 | $60.9M | Buy |
1,040,600
+761,500
| +273% | +$46M | 0.06% | 299 |
|
|
2014
Q4 | $18.3M | Sell |
279,100
-84,300
| -23% | -$5.31M | 0.02% | 868 |
|
|
2014
Q3 | $21M | Buy |
363,400
+145,300
| +67% | +$8.07M | 0.02% | 772 |
|
|
2014
Q2 | $12.3M | Buy |
218,100
+48,900
| +29% | +$2.57M | 0.01% | 1122 |
|
|
2014
Q1 | $8.7M | Sell |
169,200
-49,900
| -23% | -$2.52M | 0.01% | 1260 |
|
|
2013
Q4 | $11.6M | Buy |
219,100
+125,900
| +135% | +$6.19M | 0.01% | 1130 |
|
|
2013
Q3 | $4.17M | Buy |
93,200
+36,300
| +64% | +$1.61M | ﹤0.01% | 1911 |
|
|
2013
Q2 | $2.35M | Buy |
+56,900
| New | +$2.49M | ﹤0.01% | 2260 |
|
Other funds holding ABBV
VCM
VPM
Citigroup's ABBV Position: Q1 2026 in Review
Citigroup increased its AbbVie (ABBV) stake by 27% in Q1 2026, buying an estimated $97.2M and bringing the position to 2,089,885 shares worth $455M. The position accounts for 0.19% of the portfolio, ranked #93.
Citigroup first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $670M in Q1 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Citigroup held 2,089,885 shares of AbbVie worth $455M as of Q1 2026.
- Citigroup bought 438,228 AbbVie shares in Q1 2026, an estimated $97.2M.
- AbbVie made up 0.19% of Citigroup's portfolio in Q1 2026, its #93 holding.
- Citigroup first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Citigroup's AbbVie position peaked at $670M in Q1 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.